Provided by Tiger Fintech (Singapore) Pte. Ltd.

Denali Therapeutics Inc.

16.65
+0.15000.91%
Pre-market: 16.59-0.0600-0.36%09:12 EDT
Volume:1.63M
Turnover:27.02M
Market Cap:2.42B
PE:-6.48
High:16.85
Open:16.17
Low:16.17
Close:16.50
Loading ...
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Sep 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities